Caris Life Sciences, Inc. (CAI)

Caris Life Sciences will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

Caris Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Debt / Equity Ratio	-0.14	-0.15	-0.08
Debt / EBITDA Ratio	-2.09	-2.07	-0.62
Debt / FCF Ratio	-1.78	-1.50	-0.56
Quick Ratio	0.71	0.94	1.90
Interest Coverage	-4.74	-5.57	-15.78
Return on Equity (ROE)	10.52%	11.28%	15.92%
Return on Assets (ROA)	-	-82.01%	-82.69%
Return on Capital (ROIC)	10.02%	12.13%	16.15%
Return on Capital Employed (ROCE)	138.90%	-134.03%	-101.04%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).